| 000 | 01531 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512010258.0 | ||
| 264 | 0 | _c19900103 | |
| 008 | 199001s 0 0 eng d | ||
| 022 | _a0022-3549 | ||
| 024 | 7 |
_a10.1002/jps.2600780906 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurakami, T | |
| 245 | 0 | 0 |
_aImproved anticonvulsant activity of phenytoin by a redox brain delivery system. II: Stability in buffers and biological materials. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _cSep 1989 |
||
| 300 |
_a732-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aBuffers |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDihydropyridines |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aExcipients |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHydrolysis |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPhenytoin _xadministration & dosage |
| 650 | 0 | 4 | _aPyridinium Compounds |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 700 | 1 | _aShek, E | |
| 700 | 1 | _aPop, E | |
| 700 | 1 | _aBodor, N | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 78 _gno. 9 _gp. 732-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jps.2600780906 _zAvailable from publisher's website |
| 999 |
_c2591162 _d2591162 |
||